Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Oral Anticoagulation and Risk of Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Mechanical Thrombectomy: Data From the Nordictus Registry

  • Ramos-Araque, M.E.
  • Chavarría-Miranda, A.
  • Gómez-Vicente, B.
  • López-Cancio Martínez, E.
  • Castañón Apilánez, M.
  • Castellanos, M.
  • López Fernández, M.
  • Tejada Meza, H.
  • Marta Moreno, J.
  • Tejada García, J.
  • Beltrán Rodríguez, I.
  • de la Riva, P.
  • Díez, N.
  • Arias Rivas, S.
  • Santamaría Cadavid, M.
  • Bravo Anguiano, Y.
  • Bártulos Iglesias, M.
  • Palacio Portilla, E.J.
  • Revilla García, M.
  • Timiraos Fernández, J.J.
  • Arenaza Basterrechea, N.
  • Maciñeiras Montero, J.L.
  • Vicente Alba, P.
  • Julián Villaverde, F.J.
  • Pinedo Brochado, A.
  • Azkune, I.
  • Mar, F.M.
  • Luna, A.
  • Arenillas, J.F.
Introduction: We aimed to evaluate if prior oral anticoagulation (OAC) and its type determines a greater risk of symptomatic hemorrhagic transformation in patients with acute ischemic stroke (AIS) subjected to mechanical thrombectomy. Materials and Methods: Consecutive patients with AIS included in the prospective reperfusion registry NORDICTUS, a network of tertiary stroke centers in Northern Spain, from January 2017 to December 2019 were included. Prior use of oral anticoagulants, baseline variables, and international normalized ratio (INR) on admission were recorded. Symptomatic intracranial hemorrhage (sICH) was the primary outcome measure. Secondary outcome was the relation between INR and sICH, and we evaluated mortality and functional outcome at 3 months by modified Rankin scale. We compared patients with and without previous OAC and also considered the type of oral anticoagulants. Results: About 1.455 AIS patients were included, of whom 274 (19%) were on OAC, 193 (70%) on vitamin K antagonists (VKA), and 81 (30%) on direct oral anticoagulants (DOACs). Anticoagulated patients were older and had more comorbidities. Eighty-one (5.6%) developed sICH, which was more frequent in the VKA group, but not in DOAC group. OAC with VKA emerged as a predictor of sICH in a multivariate regression model (OR, 1.89 [95% CI, 1.01–3.51], p = 0.04) and was not related to INR level on admission. Prior VKA use was not associated with worse outcome in the multivariate regression model nor with mortality at 3 months. Conclusions: OAC with VKA, but not with DOACs, was an independent predictor of sICH after mechanical thrombectomy. This excess risk was associated neither with INR value by the time thrombectomy was performed, nor with a worse functional outcome or mortality at 3 months.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparative Proteomics Unveils LRRFIP1 as a New Player in the DAPK1 Interactome of Neurons Exposed to Oxygen and Glucose Deprivation

  • Gregorio-Rocasolano Barbany, Núria de|||0000-0001-5248-7525
  • Guirao, Verónica
  • Ponce, Jovita
  • Melià Sorolla, Marc|||0000-0002-4425-1077
  • Aliena-Valero, Alicia
  • García Serran, Alexia|||0000-0003-1630-1302
  • Salom, Juan B.|||0000-0002-4162-6101
  • Dávalos, Antoni|||0000-0003-2949-5679
  • Martí-Sistac, Octavi
  • Gasull Dalmau, Teresa|||0000-0002-9321-1741
Death-associated protein kinase 1 (DAPK1) is a pleiotropic hub of a number of networked distributed intracellular processes. Among them, DAPK1 is known to interact with the excitotoxicity driver NMDA receptor (NMDAR), and in sudden pathophysiological conditions of the brain, e.g., stroke, several lines of evidence link DAPK1 with the transduction of glutamate-induced events that determine neuronal fate. In turn, DAPK1 expression and activity are known to be affected by the redox status of the cell. To delineate specific and differential neuronal DAPK1 interactors in stroke-like conditions in vitro, we exposed primary cultures of rat cortical neurons to oxygen/glucose deprivation (OGD), a condition that increases reactive oxygen species (ROS) and lipid peroxides. OGD or control samples were co-immunoprecipitated separately, trypsin-digested, and proteins in the interactome identified by high-resolution LC-MS/MS. Data were processed and curated using bioinformatics tools. OGD increased total DAPK1 protein levels, cleavage into shorter isoforms, and dephosphorylation to render the active DAPK1 form. The DAPK1 interactome comprises some 600 proteins, mostly involving binding, catalytic and structural molecular functions. OGD up-regulated 190 and down-regulated 192 candidate DAPK1-interacting proteins. Some differentially up-regulated interactors related to NMDAR were validated by WB. In addition, a novel differential DAPK1 partner, LRRFIP1, was further confirmed by reverse Co-IP. Furthermore, LRRFIP1 levels were increased by pro-oxidant conditions such as ODG or the ferroptosis inducer erastin. The present study identifies novel partners of DAPK1, such as LRRFIP1, which are suitable as targets for neuroprotection.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Article targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke, safety and optimal dose selection in a randomized clinical trial

  • Millán Torné, Mònica|||0000-0002-4692-5936
  • Gregorio-Rocasolano Barbany, Núria de|||0000-0001-5248-7525
  • Pérez de la Ossa, Natalia|||0000-0002-6063-211X
  • Reverté, Silvia|||0000-0002-2052-9978
  • Costa Pages, Joan
  • Giner, Pilar
  • Silva, Yolanda
  • Sobrino, Tomás|||0000-0002-9760-8690
  • Rodríguez-Yáñez, Manuel
  • Nombela, Florentino
  • Campos, Francisco|||0000-0001-8665-1039
  • Serena, Joaquín|||0000-0002-4478-7744
  • Vivancos, José
  • Martí-Sistac, Octavi
  • Cortés, Jordi|||0000-0002-3764-0795
  • Dávalos, Antoni|||0000-0003-2949-5679
  • Gasull Dalmau, Teresa|||0000-0002-9321-1741
A role of iron as a target to prevent stroke-induced neurodegeneration has been recently revisited due to new evidence showing that ferroptosis inhibitors are protective in experimental ischemic stroke and might be therapeutic in other neurodegenerative brain pathologies. Ferroptosis is a new form of programmed cell death attributed to an overwhelming lipidic peroxidation due to excessive free iron and reactive oxygen species (ROS). This study aims to evaluate the safety and tolerability and to explore the therapeutic efficacy of the iron chelator and antioxidant deferoxamine mesylate (DFO) in ischemic stroke patients. Administration of placebo or a single DFO bolus followed by a 72 h continuous infusion of three escalating doses was initiated during the tPA infusion, and the impact on blood transferrin iron was determined. Primary endpoint was safety and tolerability, and secondary endpoint was good clinical outcome (clinicalTrials.gov NCT00777140). DFO was found safe as adverse effects were not different between placebo and DFO arms. DFO (40-60 mg/Kg/day) reduced the iron saturation of blood transferrin. A trend to efficacy was observed in patients with moderate-severe ischemic stroke (NIHSS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Establishment of a reproducible and minimally invasive ischemic stroke model in swine

  • Castaño Duque, Carlos|||0000-0001-9165-340X
  • Melià Sorolla, Marc|||0000-0002-4425-1077
  • García Serran, Alexia|||0000-0003-1630-1302
  • Gregorio-Rocasolano Barbany, Núria de|||0000-0001-5248-7525
  • García-Sort, Maria Rosa|||0000-0001-6531-6258
  • Hernández-Pérez, María|||0000-0001-8279-7954
  • Valls Carbó, Adrián|||0000-0002-4831-1276
  • Pino, Osvaldo
  • Grífols, Jordi|||0000-0002-7804-9846
  • Iruela-Sánchez, Alba|||0000-0002-1879-5601
  • Palomar-García, Alicia
  • Puig, Josep|||0000-0003-2791-6599
  • Martí-Sistac, Octavi
  • Dávalos, Antoni|||0000-0003-2949-5679
  • Gasull Dalmau, Teresa|||0000-0002-9321-1741
The need for advances in the management/treatment options for ischemic stroke patients requires that upcoming preclinical research uses animals with more human-like brain characteristics. The porcine brain is considered appropriate, although the presence of the rete mirabile (RM) prevents direct catheterization of the intracranial arteries to produce focal cerebral ischemia. To develop a reproducible minimally invasive porcine stroke model, a guide catheter and guide wire were introduced through the femoral artery until reaching the left RM. Using the pressure cooker technique, Squid-12 embolization material was deposited to fill, overflow, and occlude the left RM, the left internal carotid artery, and left circle of Willis wing up to the origins of the middle cerebral arteries (MCAs), mimicking the occlusion produced in the filament model in rodents. Longitudinal multimodal cerebral MRI was conducted to assess the brain damage and cerebral blood supply. The technique we describe here occluded up to the origins of the MCAs in 7 of 8 swine, inducing early damage 90 minutes after occlusion that later evolved to a large cerebral infarction and producing no mortality during the intervention. This minimally invasive ischemic stroke model in swine produced reproducible infarcts and shows translational features common to human stroke.